John Neylan

John Neylan

Teknisk/Vetenskaplig/F&U Direktör på AKARI THERAPEUTICS, PLC
72 år
Health Technology
Consumer Services
Commercial Services

Profil

John F.
Neylan
is Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc since 2022.
Formerly, Dr. Neylan was Chief Medical Officer & Senior Vice President at Angion Biomedica Corp.
from 2018 to 2022, Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018, Vice President-Research & Development at Wyeth Research from 2000 to 2008, Director at Advances In Kidney Disease & Health, Senior Vice President-Clinical Development at Genzyme Corp., Professor at Emory University, Assistant Professor at the University of California, Davis, and President of The American Society of Transplantation.
Education includes undergraduate studies at Duke University and a doctorate from Rush Medical College.

Aktiva positioner av John Neylan

FöretagPositionStart
AKARI THERAPEUTICS, PLC Teknisk/Vetenskaplig/F&U Direktör 2022-11-08

Tidigare kända positioner av John Neylan

FöretagPositionSlut
ANGN BIOM Teknisk/Vetenskaplig/F&U Direktör 2022-08-15
KERYX BIOPHARMACEUTICALS Teknisk/Vetenskaplig/F&U Direktör 2018-12-12
Företagsledare/Principal 2008-05-01
Direktör/Styrelseledamot -
President -
Se detaljerna i John Neylans erfarenhet

John Neylans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

55

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. John Neylan
40% rabatt: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU